Dextromethorphan hydrobromide 20 MG / guaifenesin 380 MG / pseudoephedrine hydrochloride 6... — RxCUI 1427998
RxNorm drug concept · Semantic clinical drug
RxCUI 1427998
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1427998
Official nameDextromethorphan hydrobromide 20 MG / guaifenesin 380 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan HBr 20 MG / guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,330 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It won't necessarily silence your cough entirely, but it does temporarily suppress the cough reflex and reduce how intense and frequent your cough is. It can also help reduce that...
- What exactly does dextromethorphan do — will it stop my cough completely?
- It depends on your child's age and the specific product. Most dextromethorphan products should not be given to children under 4 years old without a doctor's guidance. Some products...
- This is a really important question. If your antidepressant is an MAOI (monoamine oxidase inhibitor), you absolutely cannot take dextromethorphan — not while you're on it, and not...
🕸️ Concept Web — How Dextromethorphan hydrobromide 20 MG / guaifenesi... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dextromethorphan hydrobromide 20 MG / guaifenesin 380 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet
RxCUI 1427998 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 6
The active substance itself — no strength, form, or brand attached yet.
-
Dextromethorphan
3289IN -
Guaifenesin
5032IN -
Pseudoephedrine
8896IN -
Dextromethorphan / guaifenesin / pseudoephedrine
214495MIN -
Dextromethorphan hydrobromide
102490PIN -
Pseudoephedrine hydrochloride
91168PIN
-
Dextromethorphan
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextromethorphan / guaifenesin / pseudoephedrine Oral Tablet
374747SCDF -
Dextromethorphan hydrobromide / guaifenesin / pseudoephedrine hydrochloride Oral Tablet
2645434SCDFP -
Dextromethorphan / guaifenesin / pseudoephedrine Oral Product
1154866SCDG -
Dextromethorphan / guaifenesin / pseudoephedrine Pill
1154867SCDG -
Dextromethorphan hydrobromide / guaifenesin / pseudoephedrine hydrochloride Oral Product
2662344SCDGP -
Dextromethorphan hydrobromide / guaifenesin / pseudoephedrine hydrochloride Pill
2662742SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Dextromethorphan / guaifenesin / pseudoephedrine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextromethorphan hydrobromide 20 MG
1037200SCDC -
Guaifenesin 380 MG
794642SCDC -
Pseudoephedrine hydrochloride 60 MG
996721SCDC
-
Dextromethorphan hydrobromide 20 MG
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dextromethorphan hydrobromide 20 MG
SCDC · 1037200 -
Guaifenesin 380 MG
SCDC · 794642 -
Pseudoephedrine hydrochloride 60 MG
SCDC · 996721 -
Dextromethorphan / guaifenesin / pseudoephedrine Oral Tablet
SCDF · 374747 -
Dextromethorphan hydrobromide / guaifenesin / pseudoephedrine hydrochloride Oral Tablet
SCDFP · 2645434 -
Dextromethorphan / guaifenesin / pseudoephedrine Oral Product
SCDG · 1154866 -
Dextromethorphan / guaifenesin / pseudoephedrine Pill
SCDG · 1154867 -
Dextromethorphan hydrobromide / guaifenesin / pseudoephedrine hydrochloride Oral Product
SCDGP · 2662344 -
Dextromethorphan hydrobromide / guaifenesin / pseudoephedrine hydrochloride Pill
SCDGP · 2662742
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1427998 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50991-0214-01 | 100 TABLET in 1 BOTTLE (50991-214-01) | Poly-Vent DM | Poly Pharmaceuticals, Inc. | 2013-06-17 |
| 50991-0214-02 | 12 POUCH in 1 CARTON (50991-214-02) / 1 TABLET in 1 POUCH | Poly-Vent DM | Poly Pharmaceuticals, Inc. | 2013-06-17 |
Observed labelers:
Poly Pharmaceuticals, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.6289
Range $0.6289–$0.6289
· middle 50% $0.6289–$0.6289
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.